The World Market For Stents (Drug-Eluting And Bare Metal Product Markets In US, EU, Japan, India, China And ROW)
Table 3-1: Selected Marketed Bare Metal Stents, 2012
Table 3-2: Selected Bare Metal Coronary Stents, 2012
Table 3-3: Selected Marketed Drug-Eluting Stents, 2012 Table 3-4: Selected Features of Different Generations of Commercially Available Drug-eluting Stents CHAPTER FOUR: RECENT ADVANCES IN CORONARY STENTS TECHNOLOGIES Table 4-1: Selected Coronary Stents using Biodegradable Polymers, 2012 Table 4-2: Selected Coronary Polymer-free and Novel Coating Stents, 2012 Table 4-3: Selected Direct Drug Application Coronary Stents, 2012 Table 4-4: Selected Coronary Polymer and Drug-free Coating Stents, 2012 Table 4-5: Advantages and Disadvantages of Bioresorbable Stents Table 4-6: Selected Bioresorbable Coronary Stents, 2012 Table 4-7: Selected Dedicated Bifurcation Coronary Drug-Eluting Stents, 2012 Table 4-8: Selected Dedicated Small Vessels Coronary Drug-Eluting Stents, 2012 Table 4-9: Drug Release Parameters of Selected Drug-Eluting Stents CHAPTER FIVE: INDUSTRY STRUCTURE Table 5-1: Industry Structure – Major Competitors and Selected Marketed Products, 2012 Table 5-2: Significant Trends in the Coronary Stents Market, 2012 CHAPTER SIX: MARKET REVENUES AND FORECAST Table 6-1: Coronary Stents Estimated Global Market Shares, 2011 Figure 6-1: Stents Market Share, 2011 Table 6-2: Global Market Revenues for Coronary Stents ($ Millions) Figure 6-2: Global Stents Market Forecast Figure 6-3: Market Breakdown by Type of Stent (BMS, DES) Figure 6-4: Drug Eluting Stents Market Shre, 2011 Table 6-3: Global Market Revenues for Coronary Stents ($ Millions) Figure 6-5: Global Market Revenues Forecast ($ Billions)Drug-Eluting Stents, 2010-2017 Figure 6-6: Market Breakdown by Type of Stent (BMS, DES) Figure 6-7: Market Share Bare Metal Stents Table 6-4: Global Market Revenues for Coronary Bare Metal Stents, 2010-2017 (Bare Metal Stent, Drug Eluding Stent, Total) Figure 6-8: Bare Metal Stents Market 2010-2017
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV